CompoAtlas

Genestra Brands Phyto-Gen 830

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Prunus dulcis

Source : Bourgeons

Extraction ratio : 1:20

Dry plant equivalent : 0.47 mg

0.009 mLNot calculated
Olea europaea

Source : Jeunes pousses

Extraction ratio : 1:20

Dry plant equivalent : 0.47 mg

0.009 mLNot calculated
Cercis siliquastrum

Source : Bourgeons

Extraction ratio : 1:20

Dry plant equivalent : 0.47 mg

0.009 mLNot calculated

Non-medicinal ingredients

Éthanol, Glycérine, Eau purifiée

PopulationAgeQuantity per servingFrequency
Enfantsminimum: 12 years10 Goutte(s)1 Tous les jours
AdultesNot specified10 Goutte(s)1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Gemmotherapy Preparation to be used on the advice of your health care practitioner.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Product record

Licence holder
Seroyal International
NPN or DIN-HM
80012454
Status
Active licence
Licence date
14 August 2009
Revision date
10 May 2022
Form
Liquide
Route of administration
Orale
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80012454

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Olea europaea
    Read the warning, when it applies and the studies cited

    OLIVE LEAF - OLEA EUROPAEA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you pregnant or breastfeeding (EMA 2017).

    Sources cited by Health Canada (1)
    • EMA 2017: European Medicines Agency. European Union herbal monograph on Olea europaea L., folium. [Accessed 2024 November 27]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-olea-europaea-l-folium-first-version_en.pdf

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a kidney disorder (EMA 2017).

    Sources cited by Health Canada (1)
    • EMA 2017: European Medicines Agency. European Union herbal monograph on Olea europaea L., folium. [Accessed 2024 November 27]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-olea-europaea-l-folium-first-version_en.pdf

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other diuretics (EMA 2017).

    Sources cited by Health Canada (1)
    • EMA 2017: European Medicines Agency. European Union herbal monograph on Olea europaea L., folium. [Accessed 2024 November 27]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-olea-europaea-l-folium-first-version_en.pdf

    Known adverse reactions

    Condition of application: All products except those making a diuretic claim.

    When using this product diuretic effect may occur.

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Photograph the packaging

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Genestra Brands Phyto-Gen 830”, https://compoatlas.com/en/supplements/canada/80012454-genestra-brands-phyto-gen-830, updated 10 May 2022.

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line